Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02616393
Title Study of Tesevatinib in Subjects With Non-Small Cell Lung Cancer, EGFR Activating Mutation, Prior Treatment With a Tyrosine Kinase Inhibitor, and Brain Metastases or Leptomeningeal Metastases
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kadmon Corporation, LLC
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Beverly Hills Cancer Center Beverly Hills California 90211 United States Details
USC Norris Oncology/Hematology Newport Beach Newport Beach California 92663 United States Details
John Wayne Cancer Institute Santa Monica California 90404 United States Details
University of Colorado Cancer Center Aurora Colorado 80045 United States Details
Georgetown University Medical Center Washington District of Columbia 20007 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
UT M.D. Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field